Japan Tobacco Inc. (JAPAY)
| Market Cap | 84.16B +45.5% |
| Revenue (ttm) | 22.88B +12.2% |
| Net Income | 3.83B +220.7% |
| EPS | 2.16 +220.8% |
| Shares Out | n/a |
| PE Ratio | 21.99 |
| Forward PE | n/a |
| Dividend | 0.86 (3.61%) |
| Ex-Dividend Date | Dec 29, 2026 |
| Volume | 102,545 |
| Open | 23.71 |
| Previous Close | 23.64 |
| Day's Range | 23.61 - 23.78 |
| 52-Week Range | 15.74 - 23.84 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |
About Japan Tobacco
Japan Tobacco Inc., a tobacco company, engages in the manufacture and sale of tobacco products in Japan and internationally. It operates through two segments: Tobacco Business and Processed Food Business. It offers tobacco products, such as cigarettes, fine cut tobacco products, cigars, pipes, and hookah products. The company provides reduced-risk products, including heated tobacco, infused tobacco, e-vapor, traditional oral, and modern oral. Further, the company provides frozen and room-temperature products comprising frozen udon noodles, pack... [Read more]
Financial Performance
In 2025, Japan Tobacco's revenue was 3.47 trillion, an increase of 10.09% compared to the previous year's 3.15 trillion. Earnings were 510.18 billion, an increase of 184.63%.
Financial numbers in JPY Financial StatementsNews
Japan Tobacco Earnings Call Transcript: Q2 2026
Revenue and profit rose sharply in H1 2026, driven by strong tobacco and processed food performance, robust pricing, and positive FX. Full-year guidance and dividend were raised, with RRP and Ploom showing strong growth. Risks include Russia's affordability and Middle East costs.
Japan Tobacco Quarterly report: Q2 2026
Japan Tobacco has published its Q2 2026 quarterly earnings report on July 30, 2026.
Japan Tobacco Slides: Q2 2026
Japan Tobacco has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Japan Tobacco initiated with a Buy at BTIG
BTIG initiated coverage of Japan Tobacco (JAPAF) with a Buy rating and 7,060 yen price target While combustible strategy at big tobacco peers is either used as a driver of…
US FDA proposes rule to tighten oversight of foreign tobacco makers
The U.S. Food and Drug Administration proposed a rule on Friday that would require foreign tobacco product makers to register their facilities and list products sold in the country.
Japan Tobacco Earnings Call Transcript: Q1 2026
Q1 2026 saw strong revenue and profit growth, led by robust tobacco business performance and RRP momentum. Management remains confident in full-year guidance, despite geopolitical and cost risks, with increased investment planned for Q2 and beyond.
Japan Tobacco Quarterly report: Q1 2026
Japan Tobacco has published its Q1 2026 quarterly earnings report on May 8, 2026.
Japan Tobacco Slides: Q1 2026
Japan Tobacco has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 8, 2026.
Japan Tobacco Earnings Call Transcript: Q4 2025
Record FY2025 results driven by tobacco and RRP growth, with Ploom Aura expanding to 19 markets and strong pricing power offsetting industry headwinds. FY2026 guidance targets continued profit and cash flow growth, with sustained investment in innovation and shareholder returns.
Japan Tobacco Quarterly report: Q4 2025
Japan Tobacco has published its Q4 2025 quarterly earnings report on February 12, 2026.
Japan Tobacco Slides: Q4 2025
Japan Tobacco has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 12, 2026.
Japan Tobacco Earnings Call Transcript: Q3 2025
Nine-month results showed strong growth in revenue, profit, and market share, driven by robust tobacco business performance and the Vector Group acquisition. Outlook for FY2025 is revised upward, with record highs expected and a higher dividend. Risks include potential tax hikes in Russia and ongoing inflation in Turkey.
Japan Tobacco Quarterly report: Q3 2025
Japan Tobacco has published its Q3 2025 quarterly earnings report on October 30, 2025.
Japan Tobacco Slides: Q3 2025
Japan Tobacco has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 30, 2025.
Japan Tobacco Earnings Call Transcript: Q2 2025
Strong first-half results with double-digit AOP and revenue growth, driven by organic momentum and the Vector acquisition. Full-year guidance for revenue and profit was revised upward, while free cash flow was revised down due to litigation and working capital. Dividend guidance was also raised.
Japan Tobacco Quarterly report: Q2 2025
Japan Tobacco has published its Q2 2025 quarterly earnings report on July 31, 2025.
Japan Tobacco Slides: Q2 2025
Japan Tobacco has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 31, 2025.
Japan Tobacco Earnings Call Transcript: Q1 2025
Q1 2025 saw strong revenue and AOP growth, led by robust tobacco pricing and the Vector acquisition. The pharmaceutical business will be transferred to Shionogi, with a JPY 6 billion profit impact, while the dividend policy remains unchanged. FX volatility and cost increases are key risks.
Japan Tobacco Quarterly report: Q1 2025
Japan Tobacco has published its Q1 2025 quarterly earnings report on May 7, 2025.
Japan Tobacco Slides: Q1 2025
Japan Tobacco has posted slides in relation to its Q1 2025 quarterly earnings report, which was published on May 7, 2025.
Japan Tobacco Earnings Call Transcript: Q4 2024
Record-high revenue and AOP were achieved in 2024, driven by strong tobacco and RRP growth, with the Vector Group acquisition enhancing U.S. presence and currency resilience. Business Plan 2025 targets high single-digit AOP growth at constant FX, supported by continued investments and robust pricing.
Japan Tobacco Quarterly report: Q4 2024
Japan Tobacco has published its Q4 2024 quarterly earnings report on February 14, 2025.
Japan Tobacco Slides: Q4 2024
Japan Tobacco has posted slides in relation to its Q4 2024 quarterly earnings report, which was published on February 14, 2025.
Japan Tobacco Earnings Call Transcript: Q3 2024
Revenue and AOP rose year-on-year, driven by strong tobacco pricing and Ploom growth, while the Vector acquisition boosts US market share and future profit potential. Full-year guidance was revised upward, but profit is tempered by higher costs and Canadian litigation risks.
Japan Tobacco Quarterly report: Q3 2024
Japan Tobacco has published its Q3 2024 quarterly earnings report on October 31, 2024.